NCT03156595

Demonstrate the Value of Using Hypnosis in Chimiotherapy- Induced Chronic Neuropathies

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 108 (estimated)
• Sponsor: University Hospital, Strasbourg, France · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Chimiotherapy produces neuropathies injuries to 30% to 70% cases. A third of those patients keeps suffering from this side effects disabilities and their quality of life is seriously affected. Hypnosis, as a non-invasive tool without physical side effects, might be used to relieve them. the purpose of this trial based on our own experience, is to demonstrate the value of using hypnosis and self-hypnosis in chimiotherapy- induced chronic neuropathies. The aim will be to sustainably improve the quality of life by expanding self-management of pain and motor function side effect.

Conditions

• Chemotherapy-induced Neuropathy

Interventions

Type	Name	Description
BEHAVIORAL	Nurse interview	Personal interview with nurses to evaluate the relief of neuropathic pains with the reference treatment. (If necessary send to the medical team ) It's a listening time around neuropathic pain which altered the quality of life.
BEHAVIORAL	Hypnosis sessions	Hypnosis sessions with a nurse or psychologist, with deepening sessions to facilitate self-hypnosis learning.

Timeline

• Start date: 2017-08-04
• Primary completion: 2021-11-04
• Completion: 2021-11-04
• First posted: 2017-05-17
• Last updated: 2021-10-19

Locations

1 site across 1 country: France